Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease

Mattia Siciliano1, Rosa De Micco2, Valeria Sant'Elia2

  • 1Department of Advanced Medical and Surgical Sciences - MRI Research Center Vanvitelli-FISM, University of Campania "Luigi Vanvitelli", Piazza Miraglia 2, 80138, Naples, Italy; Department of Psychology, University of Campania "Luigi Vanvitelli", Viale Ellittico 31, 81100, Caserta, Italy.

PubMed
Abstract

Insights

Parkinson's disease with mild cognitive impairment may improve over time. Higher education, better attention, and memory at baseline are linked to cognitive reversion in PD-MCI patients.

Area of Science:

  • Neuroscience
  • Neurology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) is prevalent in early Parkinson's disease (PD-MCI).
  • PD-MCI exhibits variable progression, with potential for reversion to normal cognition.
  • Predictors of cognitive reversion in early PD-MCI remain unclear.

Purpose of the Study:

  • To identify baseline factors associated with reversion from PD-MCI to normal cognition.
  • To explore brain morphometric differences between PD-MCI patients who revert and those who do not.

Main Methods:

  • Longitudinal study of 134 early, drug-naïve Parkinson's disease patients.
  • Comprehensive cognitive and brain morphometric assessments at baseline and 1-year follow-up.
  • Logistic regression and comparison of cortical thickness/volumes between Reverters and Non-Reverters.

Main Results:

  • 48% of patients had PD-MCI at baseline; 24.6% reverted to normal cognition within 1 year.
  • Higher education and better attention/memory predicted reversion.
  • Reverters showed greater left inferior temporal gyrus cortical thickness.

Conclusions:

  • Higher educational attainment and preserved frontotemporal cognitive function are associated with PD-MCI reversion.
  • Increased inferior temporal lobe thickness may indicate a higher likelihood of cognitive recovery.
  • Findings aid in identifying candidates for early Parkinson's disease cognitive impairment clinical trials.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
72